Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /CYIO

CYIOS Corp.

CYIO

• OTCMKTS: CYIO • Delayed

0.0018USD 29%

As of 13 June 2026, CYIOS Corp. has a market cap of $721.97K USD, ranking #48820 globally and #6284 in the United States. It ranks #4330 in the Healthcare sector, and #355 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

48820

Country Rank

6284

Sector Rank

4330

Industry Rank

355

Key Stats

Market Cap

$721.97KUSD

Revenue (TTM)

$1.49MUSD

Net Income (TTM)

-$61.22KUSD

Profit Margin

-4.1%

PS Ratio

0.5

PB Ratio

2.3

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

John O'Shea open_in_new

Employees

Founded

1997

Website

cyioscorporation.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
29%	-33%	-48%	-39%	-67%	-33%	-80%	-92%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	CYIO CYIOS Corp ISIN: US23256Y1082 Shares Out.: Shares Outstanding: 337.594M¹ Shares Float: 149.549M² TV: TradingView: OTC: CYIO SA: Stock Analysis: OTC: CYIO YF: Yahoo Finance: CYIO GF: Google Finance: OTCMKTS: CYIO BA: Barron's: CYIO MS: Morningstar: PINX: CYIO	0.0018 USD	TV: TradingView: OTC: CYIO SA: Stock Analysis: OTC: CYIO YF: Yahoo Finance: CYIO GF: Google Finance: OTCMKTS: CYIO BA: Barron's: CYIO MS: Morningstar: PINX: CYIO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About CYIOS Corp.

CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)

Name	Market Cap (USD) diff.	PE	Country
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 4M%	-	United States
Indivior PLC LSE: INDV	$2.07B 1.54B GBP 287K%	-	United States
Endo, Inc. OTCMKTS: NDOI	$1.8B 249K%	0.4	United States
Dynavax Technologies Corp. NASDAQ: DVAX	$1.76B 244K%	-	United States
ArriVent BioPharma, Inc. NASDAQ: AVBP	$1.33B 184K%	-	United States
BellRing Brands, Inc. NYSE: BRBR	$1.02B 142K%	12.1	United States

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 5M%	24.2	Israel
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 2M%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 2M%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 2M%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 1M%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 1M%	-	France

chevron_leftBack